发明名称 |
Self-regulated apoptosis of inflammatory cells by gene therapy |
摘要 |
This invention relates to chimeric nucleic acids and to the therapeutic induction of apoptosis in activated inflammatory cells, or cells at a site of inflammation, by introducing into those cells the chimeric nucleic acid. The chimeric nucleic acid having at least one TNFalpha promoter enhancer attached to a functional copy of a TNFalpha promoter and further attached to at least one copy of an apoptosis-inducing gene, which is further attached to a 3'UTR. The apoptosis-inducing gene is Granzyme B. The invention also relates to methods of making and using self-regulated apoptosis chimeric nucleic acids and pharmaceutical compositions containing them for treating inflammatory diseases.
|
申请公布号 |
US6537784(B1) |
申请公布日期 |
2003.03.25 |
申请号 |
US19990229151 |
申请日期 |
1999.01.12 |
申请人 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. |
发明人 |
TATAKE REVATI J.;MARLIN STEVEN D.;BARTON RANDALL W. |
分类号 |
C12N15/09;A61K31/7088;A61K38/00;A61K48/00;A61P1/04;A61P3/10;A61P17/06;A61P25/00;A61P29/00;A61P31/00;A61P43/00;C07K14/525;C12N5/10;C12N9/64;C12N15/85;C12Q1/68;(IPC1-7):C12P19/34;C12N15/64;C12N15/00;C12Q1/02;C07H21/04 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|